Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Positron emission tomography (PET) studies with the selective 5-HT(1A) receptor ligand, [(11)C]WAY-100635, have indicated that the binding potential (BP) of brain 5-HT(1A) receptors is lowered in unmedicated subjects with acute major depression. However, it is unclear if these changes persist after recovery from depression. To resolve this issue, we used [(11)C]WAY-100635 in conjunction with PET imaging to compare 5-HT(1A) BP in 18 healthy controls and 14 male subjects with recurrent major depression who were clinically recovered and free of antidepressant medication. BP values, derived from a reference tissue model, were analysed by region of interest and statistical parametric mapping. Both analyses showed a widespread and substantial (17%) decrease in 5-HT(1A) receptor BP in cortical areas in the recovered depressed subjects. In contrast, 5-HT(1A) BP in the raphe nuclei did not distinguish depressed subjects from controls. Our results suggest a persistent dysfunction in cortical 5-HT(1A) BP as measured by [(11)C]WAY-100635 in recovered depressed men. Lowered 5-HT(1A) receptor binding availability could represent a trait abnormality that confers vulnerability to recurrent major depression.

Original publication

DOI

10.1038/sj.mp.4001401

Type

Journal article

Journal

Mol Psychiatry

Publication Date

04/2004

Volume

9

Pages

386 - 392

Keywords

Antidepressive Agents, Brain Mapping, Carbon Isotopes, Cerebral Cortex, Depressive Disorder, Major, Humans, Male, Matched-Pair Analysis, Middle Aged, Piperazines, Positron-Emission Tomography, Pyridines, Radiopharmaceuticals, Raphe Nuclei, Receptor, Serotonin, 5-HT1A, Reference Values, Serotonin Antagonists